Private equity firm, DPI, to inject $190 million into Alameda Healthcare, a notable healthcare company in Egypt.
In a significant move for the Egyptian healthcare sector, Development Partners International (DPI) has agreed to invest $190 million for a minority stake in Alameda Healthcare. This marks the largest healthcare investment of its kind in Egypt to date.
DPI, a global investment firm managing assets and co-investments worth over $3 billion across three funds, will join forces with Alameda Healthcare, the largest hospital operator in Egypt with over 1,000 beds. Alameda operates hospitals under two tertiary care brands: As-Salam International and Dar Al Fouad, as well as seven polyclinics across Egypt, gastroenterology and liver care centres under Elixir Gastro and Liver Care Center, and various other healthcare facilities.
The investment aims to support Alameda's expansion, enabling the company to increase its footprint and capacity. This will allow Alameda to expand access to high-quality healthcare, particularly in underserved areas of Egypt.
The transaction is subject to relevant regulatory approvals and is expected to close in the third quarter of 2025. Alameda Chairman Fahad Khater will retain his position as the majority shareholder.
While DPI has invested in the company, the identities of the co-investors involved in the deal have not been disclosed. EFG Hermes acted as the exclusive M&A financial advisor on the transaction.
The investment will also enable Alameda to train and develop medical talent, potentially reversing the brain drain of Egyptian doctors and nurses. By scaling its Centers of Excellence, Alameda will be able to offer advanced and sophisticated medical practices, further enhancing the quality of healthcare in Egypt.
Moreover, the new funding will accelerate Alameda's expansion both within Egypt and across the Gulf Cooperation Council (GCC) region. This investment is expected to drive growth and innovation in the Egyptian healthcare sector, contributing to the country's ongoing development.
[1] https://www.reuters.com/business/healthcare-pharmaceuticals/dpi-to-invest-190-million-alameda-healthcare-2023-03-21/ [2] https://www.arabianbusiness.com/companies/healthcare/alameda-healthcare-raises-1bn-to-expand-footprint-855750.html [3] https://www.arabianbusiness.com/companies/healthcare/dpi-to-invest-190-million-in-alameda-healthcare-855804.html [4] https://www.reuters.com/business/healthcare-pharmaceuticals/dpi-to-invest-190-million-alameda-healthcare-2023-03-21/ [5] https://www.arabianbusiness.com/companies/healthcare/alameda-healthcare-raises-1bn-to-expand-footprint-855750.html
The investment by DPI, a global investment firm, will be channeled into Alameda Healthcare, a significant move in the Egyptian business sector, aiming to bolster the company's financial resources for expansion and capacity increase, thereby improving access to top-tier healthcare services, particularly in underprivileged areas.
